APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression

International Journal of Geriatric Psychiatry

Volumn 18, Issue 12, 2003, Pages 1075-1081

  Butters, Meryl A ^a   Sweet, Robert A ^a   Mulsant, Benoit H ^a,d   Kamboh, M Ilyas ^a,c   Pollock, Bruce G ^a   Begley, Amy E ^a   Reynolds III, Charles F ^a   DeKosky, Steven T ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Depression; Geriatric; Late life

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC RISK; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PROTEIN LOCALIZATION; RISK FACTOR;

AGE OF ONSET; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COGNITION DISORDERS; DEPRESSIVE DISORDER; FEMALE; GENE FREQUENCY; HUMANS; MALE;

EID: 0345737212     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.1006     Document Type: Article

References (37)

1. Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. 1993a. The course of geriatric depression with 'reversible dementia': A controlled study. Am Psychiatry 150(11): 1693-1699.
2. Alexopoulos GS, Young RC, Meyers BS. 1993b. Geriatric depression: Age of onset and dementia. Biological Psychiatry 34: 141-145.
3. APA. 1994. Diagnostic and Statistical Manual of Mental Disorders (4th ed. rev) (DSM-IV). American Psychiatric Association: Washington DC, USA.
4. Copeland JRM, Davidson IA, Dewey ME, et al. 1992. Alzheimer's disease, other dementias, depression and pseudodementia: Prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry 161: 230-239.
5. Devenand DP, Sano M, Tang M, et al. 1996. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 53: 175-182.
6. Emery VO, Oxman TE. 1992. Update on the dementia spectrum of depression. Am J Psychiatry 149(3): 305-317.
7. First MB, Spitzer RL, Gibbon M, Williams JBW. 1994. Structured Clinical Interview of Axis I DSM-IV Disorders- Patient Edition (SCID-I/P, Version 2.0). Biometric Research Department, New York State Psychiatric Institute: New York.
8. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-Mental State': A practical method grading the cognitive state of patients for the clinician. J Psychiatric Res 12: 189-198.
9. Green RC, Cupples LA, Kurz A, et al. 2003. Depression as a risk factor for Alzheimer's disease: The MIRAGE Study. Arch Neurol 60: 753-759.
10. Heidrich A, Thome J, Rosler M. 1997. Apolipoprotein E-e4 allele frequency in late-onset depression. Biol Psychiatry 41: 912.
11. Hoch CC, Reynolds CF, Buysse DJ, et al. 1993. Two-year survival in patients with mixed symptoms of depression and cognitive impairment: Comparison with major depression and primary degenerative dementia. Am J Geriatr Psychiatry 1(1): 59-66.
12. Jorm AF, Van Duijn CM, Chandra V, et al. for the Eurodem Risk Factors Research Group. 1991. Psychiatric history and related exposures as risk factors for Alzheimer's disease: A collaborative re-analysis of case-control studies. Int J Epidemiol 20(2 Suppl.2): S43-S47.
13. Kamboh MI. 1995a. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. Human Biol 67: 195-215.
14. Kamboh MI. 1995b. APOE*4-associated Alzheimer's disease risk is modified by alpha 1 antichymotrypsin polymorphism. Nat Genet 10: 486-488.
15. Kessing LV, Jorgensen OS. 1999. Apolipoprotein E-e4 frequency in affective disorder. Biol Psychiatry 45: 430-434.
16. Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS. 1991. Clinical risk factors for Alzheimer's disease: A population based case-control study. Neurology 41: 1393-1397.
17. Kral VA, Emery OB. 1989. Long-term follow-up of depressive pseudodementia of the aged. Can J Psychiatry 34: 445-446.
18. Krishnan KRR, Tupler LA, Richie JC, et al. 1996. Apolipoprotein E-e4 frequency in geriatric depression. Biol Psychiatry 40: 69-71.
19. Mattis S. 1976. Mental status examination for organic mental syndrome in the elderly patient. In Geriatric Psychiatry, Bellak L, Karuso TB (eds.). Grune & Stratton: New York.
20. Mattis S. 1988. Dementia Rating Scale (DRS). Psychological Assessment Resources: Odessa, FL.
21. Mezzich JE, Fabrega H, Jr, Coffman GA, Haley R. 1989. DSM-III disorders in a large sample of psychiatric patients: Frequency and specificity of diagnoses. Am J Psychiatry 146: 212-219.
22. McCallister TW, Price TRP. 1982. Severe depressive pseudodementia with and without dementia. Am J Psychiatry 139: 626-629.
23. McKhann G, Drachman DA, Folstein MF, Katzman R, Price DL, Stadlan E. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944.
24. Molloy DW, Alemayehu E, Roberts R. 1991. A Standardized Mini-Mental State Examination (SMMSE): Its reliability compared to the traditional Mini-Mental State Examination (MMSE). Am J Psychiatry 148: 102-105.
25. Nussbaum PD. 1994. Pseudodementia: A slow death. Neuropsycholog Rev 4(2): 71-90.
26. O'Brien J, Thomas A, Ballard C, et al. 2001. Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology. Biological Psychiatry 49: 130-136.
27. Papassotiropoulos A, Bagli M, Jessen F, et al. 1999. Early-onset and late-onset depression are independent of the genetic polymorphism of apoliprotein E. Dementia Geriatr Cogn Disord 10: 258-261.
28. Rabins PV, Merchant A, Nestadt G. 1984. Criteria for diagnosing reversible dementia caused by depression: Validation by two-year follow-up. Br J Psychiatry 144: 488-492.
29. Reding M, Haycox J, Blass J. 1985. Depression in patients referred to a dementia clinic: A three-year prospective study. Arch Neurol 42: 894-896.
30. Reynolds CF, III, Kupfer DJ, Hoch CC, Stack JA, Houck PR, Sewitch DE. 1986. Two-year follow-up of elderly patients with mixed depression and dementia: Clinical and electroencephalographic sleep findings. J Am Geriatr Soc 34: 793-799.
31. Riguad AS, Traykov L, Caputo L, et al. 2001. Association of the apolipoprotein Ee4 allele with late-onset depression. Neuroepidemiol 20: 268-272.
32. Sachdev PS, Smith JS, Angus-Lepan H, Rodriguez P. 1990. Pseudodementia twelve years on. J Neurol Neurosurg Psychiatry 53: 254-259.
33. Speck CE, Kukull WA, Brenner DE, et al. 1995. History of depression as a risk factor for Alzheimer's disease. Epidemiol 6: 366-369.
34. Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Saunders AM, Breitner JCS. 1997. A twin study of late-onset depression and apolipoprotein E4 as risk factors for Alzheimer's disease. Biological Psychiatry 41: 851-856.
35. Stoudemire A, Hill CD, Morris R, Martino-Saltzman D, Lewison B. 1993. Long-term affective and cognitive outcome in depressed older adults. Am J Psychiatry 150: 896-900.
36. Van Duijn CM, Clayton DG, Chandra V, et al. 1994. Interaction between genetic and environmental risk factors for Alzheimer's disease: A reanalysis of case-control studies. EU-RODEM Risk Factors Research Group. Genetic Epidemiol 11: 539-551.
37. Zubenko GS, Henderson R, Stiffler JS, Stabler S, Rosen J, Kaplan BB. 1996. Association of the APOE ε4 allele with clinical subtypes of late life depression. Biol Psychiatry 40: 1008-1016.